Cobamamide
![]() | |
![]() | |
Systematic (IUPAC) name | |
---|---|
Coα-[α-(5,6-dimethylbenzimidazolyl)]-Coβ- (5'-deoxy-5'-adenosyl)cobamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
13870-90-1 ![]() |
ATC code | B03BA04 (WHO) |
PubChem | CID 5459907 |
ChemSpider |
16736117 ![]() |
KEGG |
D00042 ![]() |
ChEBI |
CHEBI:18408 ![]() |
Chemical data | |
Formula | C72H100CoN18O17P |
Molar mass | 1579.58 g/mol |
| |
![]() ![]() |
Cobamamide (AdoCbl), which is also known as adenosylcobalamin and dibencozide, is, along with methylcobalamin (MeCbl), one of the active forms of vitamin B12. As a nutritional supplement, it is available in tabletted form, but unlike cyanocobalamin, methylcobalamin, and hydroxocobalamin, it is not available in injectable form.
An enzyme that uses adenosylcobalamin as a cofactor is methylmalonyl-CoA mutase (MCM).
External links
|
|
This article is issued from Wikipedia - version of the Wednesday, April 06, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.